Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Key Takeaways:

• Biodesix will release its fourth quarter and full-year 2025 financial results on February 26, 2026.
• A conference call and webcast is scheduled for 4:30 p.m. Eastern Time that same day.
• Biodesix, Inc. is a leading diagnostic solutions company listed on Nasdaq (BDSX).
• This update will follow the close of trading on February 26.
• The announcement originates from Louisville, Colorado, on February 12, 2026.

The Big Announcement

Biodesix, Inc. (Nasdaq: BDSX) has confirmed it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, once trading has concluded. The announcement, made on February 12, underscores the company’s aim to keep investors, stakeholders, and the public informed about its most recent financial performance and outlook.

Company Background

Founded and based in Louisville, Colorado, Biodesix is recognized as a leading diagnostic solutions provider. Its Nasdaq listing (BDSX) highlights the organization’s strong presence in the financial markets, drawing the attention of investors and analysts in the diagnostics and broader healthcare sectors.

The Financial Update Schedule

After the close of trading on February 26, Biodesix plans to issue its formal earnings report, detailing key figures from the fourth quarter of 2025 and providing a cumulative view of the company’s annual results. Shortly thereafter, at 4:30 p.m. Eastern Time, management will conduct a conference call and webcast to discuss the company’s financial performance and broader business updates.

Investor and Public Engagement

Biodesix’s conference call offers a valuable opportunity for stakeholders to gain deeper insights into the company’s results. According to the press release, investors, analysts, and members of the public can tune in to learn about the company’s most recent achievements and future direction in the diagnostic solutions space. By combining both the release of the financial reports and the live discussion, Biodesix aims to present a comprehensive update on its progress and strategy as it moves into the next fiscal year.